Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Aglycosyl anti-CD3 monoclonal...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
Bibliographic Details
Main Authors:
Lawson, C
,
Griffiths, B
,
Ponchel, F
,
Hale, G
,
Waldmann, H
,
Isaacs, J
Format:
Conference item
Published:
2005
Holdings
Description
Similar Items
Staff View
Similar Items
The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibody.
by: Routledge, E, et al.
Published: (1995)
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
by: Isaacs, J, et al.
Published: (1992)
Humanised monoclonal antibody therapy for rheumatoid arthritis.
by: Isaacs, J, et al.
Published: (1992)
Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study.
by: Morgan, A, et al.
Published: (1997)
Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection.
by: Friend, P, et al.
Published: (1999)